Do you have expertise in, and passion for Medical Affairs in Oncology? Would you like to apply your expertise to impact the Associate Director, Global Real World Evidence (RWE) Strategy - Oncology role in a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you!
At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you're our kind of person.
AstraZeneca's vision in Oncology is to help patients by redefining the cancer-treatment paradigm, with the aim of bringing six new cancer medicines to patients between 2013 and 2020. A broad pipeline of next-generation medicines is focused principally on four disease areas - breast, ovarian, lung and hematological cancers. As well as other tumor types, these are being targeted through five key platforms - immunotherapy, the genetic drivers of cancer and resistance, DNA damage repair, HER2 and antibody drug conjugates, underpinned by personalized healthcare and biomarker technologies.
Description: The Global Real World Evidence Generation (RWEvGen) Strategy Tumor Lead role sits within the Medical Evidence Generation and External Alliance function of the OBU Global Medical Affairs (GMA) organization. The RWEvGen Strategy Tumor lead/ Europe RWEvGen lead will lead the RWE strategy for a tumor(s) or indication(s). S/he will work closely with the Global RWEvGen Strategy Tumor Area Lead/ Head of Europe RWEvGen Strategy and global cross-functional colleagues. S/he will represent the RWE Strategy perspective, globally/ at Europe level, on cross-functional teams and is responsible for the development and delivery of a centralized RWE strategy that incorporates the needs of the patient, health care provider, and payer. This position requires an experienced individual with expert scientific knowledge of RWE and execution of epidemiologic, health economic, and outcomes research studies and their application throughout the drug development process. The role also requires strong leadership skills, business acumen, and excellent interpersonal skills.
Minimum Qualification Requirements Education:
- As the RWE Strategy (RWES) Tumor Lead, the Associate Director will hold the overarching accountability for the development and execution of RWE strategy for a tumor within Oncology franchises. The responsibilities include, but are not limited to:
- Critically appraising the changing scientific and commercial environment and synthesizing pertinent information into actionable and impactful RWE strategies as a direct contribution to the Oncology TA Leadership Team.
- Overseeing the development and design of the RWES in collaboration with the broader Medical Evidence Generation an External Alliance function to support articulation of a products clinical and economic value.
- Providing RWE input to Global tumor strategy and medical plans, payer-related evidence plans, and regulatory strategies.
- Participate in the evidence generation planning process and resolution of complex issues, especially those involving RWE
- Fostering collaborative relationships with expert investigators in external academic institutions and research organizations and with internal stakeholders.
- Guiding the development of publication planning strategies and presentation/publication of scientific data at major medical and scientific meetings and in peer-reviewed journals.
- Prioritizing research activities, resources, and focus in the face of rapidly evolving product timelines in accordance with the RWES.
- Ensure inclusion and capturing of patient perspective where applicable and collaboration with the Patient Centered Science team to ensure inclusion of a patient-focused approach in the broader RWES
Doctoral/Masters degree in a relevant field (e.g., health economics, outcomes research, health services research, epidemiology, health economics, health policy or related fields)Experience:
Skills and Capabilities:
- 5 years of relevant experience (e.g., academia, consulting, and/or industry); a minimum of 3 years in the pharmaceutical/biotechnology industry.
- Demonstrated subject matter expertise in the design and conduct of observational research in Oncology is required; additional clinical expertise at different phases of drug development is preferred
- Experience in global (ex-US) markets is a plus
- Expert research and analysis skills and a track record of scientific publications. Ability to work effectively, independently, and in a matrix team environment.
- Excellent communication, interpersonal, and organizational skills.
- Will work on projects of diverse scope and complexity as a skilled specialist with advanced theoretical knowledge and practical training. Expected to exercise independent judgment within generally defined practices, guidance, and policies. Expected to represent AstraZeneca in external interactions with scientific, policy, and/or regulatory groups.
- Should be highly motivated and work well with minimal supervision.
At AstraZeneca when we see an opportunity for change, we seize it and make it happen, because any opportunity no matter how small, can be the start of something big. Delivering life-changing medicines is about being entrepreneurial - finding those moments and recognizing their potential. Join us on our journey of building a new kind of organization to reset expectations of what a bio-pharmaceutical company can be. This means we're opening new ways to work, pioneering cutting edge methods and bringing unexpected teams together. Interested? Come and join our journey.
Are you already imagining yourself joining our team? Good, because we can't wait to hear from you.